Middle-Late Jurassic magmatism in the west central Lhasa subterrane, Tibet: Petrology, zircon chronology, elemental and Sr-Nd-Pb-Hf-Mg isotopic geochemistry

Mesozoic magmatic rocks are widespread in the Lhasa terrane, but most of them are of cretaceous age. Because Jurassic rocks are relatively rare and our knowledge on such earlier magmatism in the context of the tectonic setting and evolution is limited. In this study, we focus on the mid-late Jurassic granitoids that occur in the west central Lhasa subterrane. We present the results of a systematic study of these granitoid rocks of tonalite composition together with the hosted mafic magmatic enclaves. We dated 4 representative tonalite samples and 2 enclaves using zircon U-Pb method that gives the age range of 167–154 Ma. All these samples have Sr-Nd-Pb isotopic compositions (87Sr/86Sr = 0.713941–0.718417, εNd(t) = −14 to −9.8, 206Pb/204Pb = 18.806–18.936, 207Pb/204Pb = 15.739–15.764, 208Pb/204Pb = 39.257–39.798) similar to the composition of gneisses from the basement of the Lhasa terrane, suggesting that magmas parental to these mid-late Jurassic granitoids of tonalitic composition are of largely crustal origin, which is also supported by the petrographic observations. Both of the tonalite samples and the mafic enclaves have a wide span of zircon εHf(t) of −15.9 to −0.2 and − 13.8 to −7.4, respectively. These samples also show varying δ26Mg ranging from −0.40 to −0.18, with an average δ26Mg = −0.27 ± 0.06‰ (2SD) that is best understood as representing the Mg composition of the continental crust of the Lhasa terrane. All these observations allow us to conclude that basaltic melts derived from metasomatized mantle were involved in the petrogenesis of these granitoids. Specifically, southward subduction of the Bangong-Nujiang Ocean lithosphere and subsequent slab rollback metasomatized the mantle wedge and the lithospheric mantle above, whose melting produced basaltic magmas. Underplating and intrusion of these basaltic magmas caused crustal melting and generation of granitoid magmas parental to the tonalite and enclaves we study

Letrozole versus Clomiphene for Infertility in the Polycystic Ovary Syndrome

BACKGROUND Clomiphene is the current first-line infertility treatment in women with the polycystic ovary syndrome, but aromatase inhibitors, including letrozole, might result in better pregnancy outcomes. Full Text of Background... METHODS In this double-blind, multicenter trial, we randomly assigned 750 women, in a 1:1 ratio, to receive letrozole or clomiphene for up to five treatment cycles, with visits to determine ovulation and pregnancy, followed by tracking of pregnancies. The polycystic ovary syndrome was defined according to modified Rotterdam criteria (anovulation with either hyperandrogenism or polycystic ovaries). Participants were 18 to 40 years of age, had at least one patent fallopian tube and a normal uterine cavity, and had a male partner with a sperm concentration of at least 14 million per milliliter; the women and their partners agreed to have regular intercourse with the intent of conception during the study. The primary outcome was live birth during the treatment period. Full Text of Methods... RESULTS Women who received letrozole had more cumulative live births than those who received clomiphene (103 of 374 [27.5%] vs. 72 of 376 [19.1%], P=0.007; rate ratio for live birth, 1.44; 95% confidence interval, 1.10 to 1.87) without significant differences in overall congenital anomalies, though there were four major congenital anomalies in the letrozole group versus one in the clomiphene group (P=0.65). The cumulative ovulation rate was higher with letrozole than with clomiphene (834 of 1352 treatment cycles [61.7%] vs. 688 of 1425 treatment cycles [48.3%], P Full Text of Results... CONCLUSIONS As compared with clomiphene, letrozole was associated with higher live-birth and ovulation rates among infertile women with the polycystic ovary syndrome. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and others; ClinicalTrials.gov number, NCT00719186.

Genetic modifiers of hypertension in soluble guanylate cyclase α1–deficient mice

Nitric oxide (NO) plays an essential role in regulating hypertension and blood flow by inducing relaxation of vascular smooth muscle. Male mice deficient in a NO receptor component, the α1 subunit of soluble guanylate cyclase (sGCα1), are prone to hypertension in some, but not all, mouse strains, suggesting that additional genetic factors contribute to the onset of hypertension. Using linkage analyses, we discovered a quantitative trait locus (QTL) on chromosome 1 that was linked to mean arterial pressure (MAP) in the context of sGCα1 deficiency. This region is syntenic with previously identified blood pressure–related QTLs in the human and rat genome and contains the genes coding for renin. Hypertension was associated with increased activity of the renin-angiotensin-aldosterone system (RAAS). Further, we found that RAAS inhibition normalized MAP and improved endothelium-dependent vasorelaxation in sGCα1-deficient mice. These data identify the RAAS as a blood pressure–modifying mechanism in a setting of impaired NO/cGMP signaling